24
Participants
Start Date
January 29, 2014
Primary Completion Date
February 26, 2014
Study Completion Date
February 26, 2014
"Reumoxicam® 15 mg tablets (PJSC Farmak, Ukraine)"
One tablet was administered orally and swallowed at once, without chewing, by study volunteers, followed by 200 ml of water, under fasting condition (after preliminary nocturnal fasting for 12 hours) in the morning at 8:00 hours on Day I Period I and Period II of the study.
"Movalis 15 mg tablets (Boehringer Ingelheim Ellas A.E., Greece)"
One tablet was administered orally and swallowed at once, without chewing, by study volunteers, followed by 200 ml of water, under fasting condition (after preliminary nocturnal fasting for 12 hours) in the morning at 8:00 hours on Day I Period I and Period II of the study.
"Joint Stock Company Farmak"
INDUSTRY